{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:21:48Z","timestamp":1794936108223,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary aldosteronism (PA) is a well-known cause of secondary hypertension. We have long performed the simple standing test in patients with PA. On the other hand, there are few reports on the usefulness of the simple standing test in PA. This study is a single-center, retrospective, observational study. A total of 173 patients with hypertension or adrenal tumor admitted to Kawasaki Medical School were included. Eighty patients who met the exclusion criteria were excluded, and 31 patients without PA (non-PA), 26 patients with unilateral PA, and 36 patients with bilateral PA were included in the study. The simple standing test was performed after 120\u00a0min of standing or sitting followed, and the aldosterone\/renin ratio (ARR) and percentage of increase plasma aldosterone concentration (%increase of PAC) was calculated. The mean ARR in the simple standing test in unilateral PA (1143 (528\u20132200)) and bilateral PA subjects (521 (374\u2013765)) were significantly higher compared to non-PA subjects (152 (102\u2013240)) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, <jats:italic>p<\/jats:italic>\u2009=\u20090.0013, respectively). The percentage increase of PAC after standing loading was significantly lower in unilateral PA subjects (110 (96\u2013140)) compared to non-PA subjects (187 (155\u2013244)) (<jats:italic>p<\/jats:italic>\u2009=\u20090.0003), with no difference between non-PA and bilateral PA subjects (<jats:italic>p<\/jats:italic>\u2009=\u20090.99). The cutoff value of the ARR in the simple standing test for diagnosis of PA in this study was 364 (AUC\u2009=\u20090.948, sensitivity\u2009=\u200983.8%, specificity\u2009=\u200993.5%, false positive rate\u2009=\u20093.7%, false negative rate\u2009=\u200925.6%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), which was not inferior to the diagnostic performance of the captopril loading test. The diagnostic performance of the simple standing test for PA was not inferior to that of the captopril loading test. The percentage increase of PAC in unilateral PA subjects was significantly lower compared to bilateral PA subjects. These results demonstrate the usefulness of the simple standing test, which can be performed simultaneously with general screening tests of PA.<\/jats:p>","DOI":"10.1038\/s41598-023-40574-y","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T09:02:38Z","timestamp":1692262958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Simple standing test without furosemide is useful in the diagnosis of primary aldosteronism"],"prefix":"10.1038","volume":"13","author":[{"given":"Yuichiro","family":"Iwamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Takenouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukino","family":"Katakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminori","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoatsu","family":"Mune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kaneto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"key":"40574_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1001\/jama.1965.03090030022005","volume":"193","author":"JW Conn","year":"1965","unstructured":"Conn, J. W. et al. Normokalemic primary aldosteronism. A detectable cause of curable \u201cessential\u201d hypertension. Jama 193, 200\u20136 (1965).","journal-title":"Jama"},{"issue":"11","key":"40574_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","volume":"18","author":"AF Turcu","year":"2022","unstructured":"Turcu, A. F., Yang, J. & Vaidya, A. Primary aldosteronism - a multidimensional syndrome. Nat. Rev. Endocrinol. 18(11), 665\u2013682 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"10","key":"40574_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1055\/s-0029-1224200","volume":"41","author":"E Born-Frontsberg","year":"2009","unstructured":"Born-Frontsberg, E. et al. Tumor size of Conn\u2019s adenoma and comorbidities. Horm. Metab. Res. 41(10), 785\u2013788 (2009).","journal-title":"Horm. Metab. Res."},{"key":"40574_CR4","doi-asserted-by":"crossref","unstructured":"Sconfienza, E., et al., Prevalence of functioning adrenal incidentalomas: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab, 2023.","DOI":"10.1210\/clinem\/dgad044"},{"issue":"6","key":"40574_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1055\/s-0029-1243619","volume":"42","author":"CE Gomez-Sanchez","year":"2010","unstructured":"Gomez-Sanchez, C. E. et al. Progress in primary aldosteronism: present challenges and perspectives. Horm Metab. Res. 42(6), 374\u2013381 (2010).","journal-title":"Horm Metab. Res."},{"key":"40574_CR6","doi-asserted-by":"publisher","first-page":"1032070","DOI":"10.3389\/fendo.2022.1032070","volume":"13","author":"KF Hua","year":"2022","unstructured":"Hua, K. F., Wu, Y. H. & Zhang, S. T. Clinical diagnostic value of liquid chromatography-tandem mass spectrometry method for primary aldosteronism in patients with hypertension: A systematic review and meta-analysis. Front. Endocrinol. (Lausanne) 13, 1032070 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"40574_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","volume":"31","author":"VM Montori","year":"2002","unstructured":"Montori, V. M. & Young, W. F. Jr. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol. Metab. Clin. North Am. 31(3), 619\u201332 (2002).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"9","key":"40574_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.medcli.2021.10.012","volume":"158","author":"M Araujo-Castro","year":"2022","unstructured":"Araujo-Castro, M. & Parra-Ram\u00edrez, P. Diagnosis of primary hyperaldosteronism. Med. Clin. (Barc) 158(9), 424\u2013430 (2022).","journal-title":"Med. Clin. (Barc)"},{"issue":"9","key":"40574_CR9","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1210\/jcem.86.9.7867","volume":"86","author":"D Hirohara","year":"2001","unstructured":"Hirohara, D. et al. Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. J. Clin. Endocrinol. Metab. 86(9), 4292\u20134298 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"40574_CR10","first-page":"1020","volume":"77","author":"T Mune","year":"1993","unstructured":"Mune, T. et al. Reduced response to metoclopramide and anomalous rising response to upright posture of plasma aldosterone concentration in Japanese patients with aldosterone-producing adenoma. J. Clin. Endocrinol. Metab. 77(4), 1020\u20131027 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"40574_CR11","doi-asserted-by":"publisher","first-page":"e865","DOI":"10.1210\/clinem\/dgab611","volume":"107","author":"C Teresa Fuss","year":"2022","unstructured":"Teresa Fuss, C. et al. Reassessment of postural stimulation testing as a simple tool to identify a subgroup of patients with unilateral primary aldosteronism. J. Clin. Endocrinol. Metab. 107(2), e865\u2013e873 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"40574_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11154-011-9164-6","volume":"12","author":"Y Takeda","year":"2011","unstructured":"Takeda, Y., Karashima, S. & Yoneda, T. Primary aldosteronism, diagnosis and treatment in Japan. Rev. Endocr. Metab. Disord. 12(1), 21\u201325 (2011).","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"5","key":"40574_CR13","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder, J. W. et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889\u2013916 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"40574_CR14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/jch.14558","volume":"24","author":"WC Huang","year":"2022","unstructured":"Huang, W. C. et al. Who should be screened for primary aldosteronism? A comprehensive review of current evidence. J. Clin. Hypertens. (Greenwich) 24(9), 1194\u20131203 (2022).","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"3","key":"40574_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1161\/HYPERTENSIONAHA.118.11382","volume":"72","author":"TA Williams","year":"2018","unstructured":"Williams, T. A. et al. Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism. Hypertension 72(3), 641\u2013649 (2018).","journal-title":"Hypertension"},{"issue":"6","key":"40574_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1055\/a-1299-1878","volume":"193","author":"C Loberg","year":"2021","unstructured":"Loberg, C. et al. Update: Selective adrenal venous sampling (AVS) - Indication, technique, and significance. Rofo 193(6), 658\u2013666 (2021).","journal-title":"Rofo"},{"key":"40574_CR17","doi-asserted-by":"crossref","unstructured":"Kolo\u0161ov\u00e1, B., et al., Validation of existing clinical prediction tools for primary aldosteronism subtyping. Diagnostics (Basel), 2022. 12(11).","DOI":"10.3390\/diagnostics12112806"},{"issue":"2","key":"40574_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1365-2265.2011.04202.x","volume":"76","author":"JH Lau","year":"2012","unstructured":"Lau, J. H. et al. A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism. Clin. Endocrinol. (Oxf.) 76(2), 182\u2013188 (2012).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"8","key":"40574_CR19","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1210\/jc.2002-022051","volume":"88","author":"EA Espiner","year":"2003","unstructured":"Espiner, E. A. et al. Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J. Clin. Endocrinol. Metab. 88(8), 3637\u20133644 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"40574_CR20","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1210\/jc.2007-2055","volume":"93","author":"P Mulatero","year":"2008","unstructured":"Mulatero, P. et al. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J. Clin. Endocrinol. Metab. 93(4), 1366\u20131371 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"40574_CR21","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1210\/jcem-37-5-765","volume":"37","author":"A Ganguly","year":"1973","unstructured":"Ganguly, A. et al. Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia. J. Clin. Endocrinol. Metab. 37(5), 765\u2013775 (1973).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"40574_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12902-023-01281-x","volume":"23","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Significance of computed tomography combined with postural stimulation test in predicting laterality of primary aldosteronism. BMC Endocr. Disord. 23(1), 32 (2023).","journal-title":"BMC Endocr. Disord."},{"issue":"11","key":"40574_CR23","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1210\/clinem\/dgac460","volume":"107","author":"P Mulatero","year":"2022","unstructured":"Mulatero, P. et al. Approach to the patient on antihypertensive therapy: screen for primary aldosteronism. J. Clin. Endocrinol. Metab. 107(11), 3175\u20133181 (2022).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40574-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40574-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40574-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T23:09:49Z","timestamp":1700262589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40574-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40574"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-40574-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"20 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.K. has received honoraria for lectures, received scholarship grants, and received research grant from Novo Nordisk Pharma, Sanofi, Eli Lilly, Boehringer Ingelheim, Taisho Pharma, Sumitomo Dainippon Pharma, Takeda Pharma, Ono Pharma, Daiichi Sankyo, Mitsubishi Tanabe Pharma, Kissei Pharma, MSD, AstraZeneca, Astellas, Novartis, Kowa, Abbott. K.K. has been an advisor to, received honoraria for lectures from, and received scholarship grants from Novo Nordisk Pharma, Sanwa Kagaku, Takeda, Taisho Pharma, MSD, Kowa, Sumitomo Dainippon Pharma, Novartis, Mitsubishi Tanabe Pharma, AstraZeneca, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Sanofi. All other authors have no conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13381"}}